Maralixibat for treating type 2 progressive familial intrahepatic cholestasis ID3818
Proposed [GID-HST10040] Expected publication date: TBC
Proposed [GID-HST10040] Expected publication date: TBC
Proposed [GID-HST10043] Expected publication date: TBC
Proposed [GID-HST10020] Expected publication date: TBC
Proposed [GID-HST10019] Expected publication date: TBC
Proposed [GID-HST10034] Expected publication date: TBC
Proposed [GID-HST10039] Expected publication date: TBC
Proposed [GID-HST10030] Expected publication date: TBC
Proposed [GID-HST10037] Expected publication date: TBC
Proposed [GID-HST10022] Expected publication date: TBC
Proposed [GID-HST10038] Expected publication date: TBC
We are listening to your views on this NICE guideline. Comments close 26 March 2021.
We are listening to your views on this NICE guideline. Comments close 24 March 2021.
We are listening to your views on this NICE guideline. Comments close 22 January 2021.
We are listening to your views on this NICE guideline. Comments close 19 March 2021.
We are listening to your views on this NICE guideline. Comments close 16 March 2021.
We are listening to your views on this interventional procedures guidance. Comments close 25 February 2021.
We are listening to your views on this interventional procedures guidance. Comments close 25 February 2021.
We are listening to your views on this interventional procedures guidance. Comments close 25 March 2021.
We are listening to your views on this interventional procedures guidance. Comments close 25 March 2021.
We are listening to your views on this interventional procedures guidance. Comments close 25 March 2021.